| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/11/2011 | US20110195964 Novel cyclic benzimidazole derivatives useful as anti-diabetic agents |
| 08/11/2011 | US20110195963 Novel carbamoyloxy arylalkanoyl arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound |
| 08/11/2011 | US20110195960 Inhibitors of c-fms kinase |
| 08/11/2011 | US20110195957 Substituted diazepan orexin receptor antagonists |
| 08/11/2011 | US20110195024 Isatin derivatives for use as in vivo imaging agents |
| 08/11/2011 | US20110193074 Novel compound and organic device using same |
| 08/11/2011 | CA2789279A1 1,2,4-triazine-4-amine derivatives |
| 08/10/2011 | EP2354134A1 2h-chromene compound and derivative thereof |
| 08/10/2011 | EP2354124A2 Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives |
| 08/10/2011 | EP2352731A1 Gamma secretase modulators |
| 08/10/2011 | EP2352729A1 Melanocortin receptor antagonist compounds, process for preparing them and use thereof in human medicine and cosmetics |
| 08/10/2011 | EP2352728A1 Melanocortin receptor modulators, process for preparing them and use thereof in human medicine and cosmetics |
| 08/10/2011 | EP2352374A1 Novel cyclic benzimidazole derivatives useful anti-diabetic agents |
| 08/10/2011 | EP2265580B1 Novel method for the production of sulphonylpyrroles as hdac inhibitors |
| 08/10/2011 | EP2203431B1 Anti-infective pyrimidines and uses thereof |
| 08/10/2011 | EP2190815B1 Pyrrolidine aryl-ether as nk3 receptor antagonists |
| 08/10/2011 | EP1948603B1 Tetrahydroindole derivatives for treatment of alzheimer's disease |
| 08/10/2011 | EP1928840B1 1H-Pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors |
| 08/10/2011 | EP1841760B1 Pyrimidine derivatives as kinase modulators and method of use |
| 08/10/2011 | CN102149708A Pyrrolidin-2-ones as HDM2 ligands |
| 08/10/2011 | CN102149707A Imidazole and triazole compounds, use thereof and agents containing said compounds |
| 08/10/2011 | CN102149688A New benzimidazole derivatives |
| 08/10/2011 | CN102149685A Isoquinolinone derivatives as NK3 antagonists |
| 08/10/2011 | CN102149680A Nitrogen-containing aromatic heterocyclyl compound |
| 08/10/2011 | CN102146215A Pentamethylcyanine fluorescent dye and preparation method and application thereof |
| 08/10/2011 | CN102146053A 2-phenoxy- and 2-phenylsulfonamide derivatives with CCR3 antagonistic activity for the treatment of inflammatory or immunological disorders |
| 08/10/2011 | CN101233128B Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 08/09/2011 | US7994317 sEH inhibitors and their use |
| 08/09/2011 | US7994316 1,3,5-triazine derivative, production method thereof and organic electroluminescence device comprising this as a composing component |
| 08/09/2011 | US7994313 Unsolvated benzodiazepine compositions and methods |
| 08/09/2011 | US7994204 Binding inhibitor of sphingosine-1-phosphate |
| 08/09/2011 | US7994182 Quinazolinone-derivatives and their use for preparation of pharmaceutical compositions having PARP enzyme inhibitory effect |
| 08/09/2011 | US7994177 Therapeutic agents useful for treating pain |
| 08/09/2011 | US7994176 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/09/2011 | US7994167 Pentafluorosulphanyl-substituted compound and its use for producing medicaments |
| 08/09/2011 | US7994163 6-substituted-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists |
| 08/09/2011 | CA2612398C Helix 12 directed non-steroidal antiandrogens |
| 08/09/2011 | CA2520027C 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 08/09/2011 | CA2445190C Indole, azaindole and related heterocyclic amidopiperazine derivatives |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2432568C Benzoylpyridazines |
| 08/09/2011 | CA2422589C Pyridazinone and triazinone compounds and use thereof as pharmaceutical preparations |
| 08/05/2011 | DE202006020979U1 Stabiles mikronisiertes Candesartan-Cilexetil Stable micronized candesartan cilexetil |
| 08/04/2011 | WO2011094545A2 Compositions and methods for enhancing proteasome activity |
| 08/04/2011 | WO2011093365A1 Nitrogenated heterocyclic compound |
| 08/04/2011 | WO2011092695A1 Quinazoline-based t cell proliferation inhibitors |
| 08/04/2011 | WO2011092666A1 An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof |
| 08/04/2011 | WO2011092664A1 Crystalline forms of l-malic acid salt of sunitinib |
| 08/04/2011 | WO2011092547A1 Triazine-aryl-bis-indoles and process for preparation thereof |
| 08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | WO2011031100A3 Aripiprazole-bentonite-aea hybrid, pharmaceutical composition containing the same and method for preparing the same |
| 08/04/2011 | WO2011031073A3 Novel tetra-aza macrocyclic compound, method for preparing same, and use thereof |
| 08/04/2011 | WO2011028947A3 Heterocyclic compounds for the inhibition of pask |
| 08/04/2011 | US20110190508 Preparation of 1,7'-dimethyl-2'-propyl-2,5'-bi-1h-benzimidazole |
| 08/04/2011 | US20110190507 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 08/04/2011 | US20110190495 N-butyramide, the preparation method and use thereof |
| 08/04/2011 | US20110190366 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
| 08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
| 08/04/2011 | US20110190351 Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same |
| 08/04/2011 | US20110190343 Hiv-1 fusion inhibitors and methods |
| 08/04/2011 | US20110190318 Pharmaceutical dosage form for immediate release of an indolinone derivative |
| 08/04/2011 | US20110190315 Indoline scaffold shp-2 inhibitors and cancer treatment method |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190283 Fab I Inhibitors |
| 08/04/2011 | US20110190280 Thiazole And Oxazole Kinase Inhibitors |
| 08/04/2011 | US20110190279 Sulfur-containing heterocyclic derivative having beta secretase inhibitory activity |
| 08/04/2011 | US20110190272 Chemical compounds |
| 08/04/2011 | US20110190264 Compounds and compositions as kinase inhibitors |
| 08/04/2011 | US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/04/2011 | US20110190261 MAPK/ERK Kinase Inhibitors |
| 08/04/2011 | US20110190259 Compounds and compositions as protein kinase inhibitors |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190248 Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
| 08/04/2011 | US20110189118 Cosmetic composition, cosmetic treatment method, and compound |
| 08/04/2011 | US20110186821 Azapyrenes for electronic applications |
| 08/04/2011 | CA2788709A1 Crystalline forms of l-malic acid salt of sunitinib |
| 08/04/2011 | CA2787785A1 Compositions and methods for enhancing proteasome activity |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | CA2761509A1 Triazine-aryl-bis-indoles and process for preparation thereof |
| 08/03/2011 | EP2351751A1 Substituted pyrazolopyrimidines |
| 08/03/2011 | EP2351745A1 Pyrazine derivatives and use as PI3K inhibitors |
| 08/03/2011 | EP2351737A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350073A1 3H-IMIDAZO[4,5-b]PYRIDINE-6-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS |
| 08/03/2011 | EP2350060A2 Melanocortin receptor agonists |
| 08/03/2011 | EP2350059A2 Multiheteroaryl compounds as inhibitors of h-pgds and their use for treating prostaglandin d2 mediated diseases |
| 08/03/2011 | EP2350057A2 Novel salts of sunitinib |
| 08/03/2011 | EP2350056A1 Process for preparing a 3-pyrrole subsituted 2-indolinone malate salt |
| 08/03/2011 | EP2350055A1 Lenalidomide solvates and processes |
| 08/03/2011 | EP2350054A1 Azetidine derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350051A1 Pyridine, bicyclic pyridine and related analogs as sirtuin modulators |
| 08/03/2011 | EP2350049A2 P38 map kinase inhibitors |
| 08/03/2011 | EP2350023A1 6-phenyl-pyrimidin-4-yl-(phenylamine or phenoxy) derivatives useful as modulators of nicotinic acetylcholine receptors |
| 08/03/2011 | EP2350020A1 Spiro-imidazolone derivatives as glucagon receptor antagonists |
| 08/03/2011 | EP2350017A1 Amide compounds useful in therapy |
| 08/03/2011 | EP2350002A1 Novel compounds as calcium channel blockers |
| 08/03/2011 | EP2349998A2 A novel process for the preparation of eletriptan |
| 08/03/2011 | EP2349995A1 Selective seprase inhibitors |
| 08/03/2011 | EP2349994A1 Pesticidal (hetero) arylpyrrolidines |
| 08/03/2011 | EP2349273A1 Modulators of cxcr7 |